UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044641
Receipt number R000050990
Scientific Title Reliability, validity and responsiveness of the ICU Medical Research Council-sum score and changing of muscle strength in the Intensive Care Unit.
Date of disclosure of the study information 2021/06/24
Last modified on 2021/12/23 10:57:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reliability, validity and responsiveness of the ICU Medical Research Council-sum score and changing of muscle strength in the Intensive Care Unit.

Acronym

Reliability, validity and responsiveness of the ICU Medical Research Council-sum score and changing of muscle strength in the Intensive Care Unit.

Scientific Title

Reliability, validity and responsiveness of the ICU Medical Research Council-sum score and changing of muscle strength in the Intensive Care Unit.

Scientific Title:Acronym

Reliability, validity and responsiveness of the ICU Medical Research Council-sum score and changing of muscle strength in the Intensive Care Unit.

Region

Japan


Condition

Condition

Patients who admitted in the ICU

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To detect reliability, validity and responsiveness of the ICU Medical Research Council-sum score in the Intensive Care Unit.

Basic objectives2

Others

Basic objectives -Others

To detect changing of muscle strength in the Intensive Care Unit.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The intra-class correlation coefficient on the MRC score at Initial Assessment.

Key secondary outcomes

MRC and Handgrip Strength at Initial, ICU discharge and Hospital discharge.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All mechanical ventilated patients in the ICU

Key exclusion criteria

1. under 18 years old
2. ICU stay <48 hours
3. Extubated within 48 hours after ICU admission
4. Unclear consciousness during 5 days after ICU admission
5. Neuro patients
6. Cannot get Patient's consent
7. Richmond agitation sedation scale (RASS) at muscle strength assessment of less than -3 and +2 or more.
8. Patients using muscle relaxants

Target sample size

55


Research contact person

Name of lead principal investigator

1st name Hajime
Middle name
Last name Katsukawa

Organization

Yonemori Hospital

Division name

Rehabilitation

Zip code

890-0062

Address

1-17-1 Yojiro Kagoshima- City Kagoshima, Japan

TEL

099-230-0100

Email

winegood21@gmail.com


Public contact

Name of contact person

1st name Hajime
Middle name
Last name Katsukawa

Organization

Yonemori Hospital

Division name

Rehabilitation

Zip code

890-0062

Address

1-17-1 Yojiro Kagoshima- City Kagoshima, Japan

TEL

099-230-0100

Homepage URL


Email

winegood21@gmail.com


Sponsor or person

Institute

Yonemori Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yonemori Hospital

Address

1-17-1 Yojiro Kagoshima- City Kagoshima, Japan

Tel

099-230-0100

Email

n-sugiyasu@yk2.so-net.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2021 Year 06 Month 28 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 06 Month 24 Day

Last modified on

2021 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050990


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name